- Investing Ideas
- /
- U.S. Fast Growing Stocks With High Insider Ownership
U.S. Fast Growing Stocks With High Insider Ownership
UPDATED May 16, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
187 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$19.10 | 10.1% | 87.4% | US$3.1b | US$26.42 | PS19x | E123.6% | n/a | Semiconductors | ||
HSCS | US$11.31 | 25.8% | -86.8% | US$5.9m | n/a | PS39865.7x | E66.8% | n/a | Healthcare | ||
NEON | US$2.25 | -13.8% | -69.0% | US$35.5m | US$3.00 | PS8.2x | E158.0% | n/a | Tech | ||
ZS | US$179.31 | 4.3% | 44.7% | US$27.1b | US$258.54 | PS14.2x | E41.6% | n/a | Software | ||
HOFV | US$3.03 | -1.0% | -55.2% | US$20.0m | US$8.00 | PB0.2x | E71.1% | n/a | Consumer Services | ||
HSAI | US$5.15 | -0.1% | -38.5% | US$679.5m | US$11.00 | PS2.5x | E68.5% | n/a | Automobiles | ||
LOOP | US$2.75 | -2.5% | -11.0% | US$133.1m | US$7.25 | PS1081.7x | E65.6% | n/a | Materials | ||
SMSI | US$2.69 | 14.7% | -73.2% | US$25.7m | US$14.67 | PB0.6x | E76.7% | n/a | Software | ||
SPRY | US$9.10 | 3.4% | 17.4% | US$860.4m | US$19.00 | PS88174.7x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
CVCY | US$19.89 | 3.6% | -1.1% | US$235.3m | US$23.75 | PB1.1x | E39.8% | 2.4% | Banks | ||
FTCI | US$0.49 | -11.8% | -83.9% | US$63.7m | n/a | PB1.1x | E74.9% | n/a | Capital Goods | ||
BYRN | US$11.99 | -11.3% | 121.6% | US$284.2m | US$16.63 | PS5.4x | E109.7% | n/a | Capital Goods | ||
AMPS | US$3.99 | -12.3% | -17.6% | US$666.7m | US$7.06 | PS3.8x | E71.7% | n/a | Utilities | ||
BFRI | US$1.09 | -31.0% | -88.3% | US$6.2m | US$16.00 | PB1.2x | E64.2% | n/a | Pharmaceuticals & Biotech | ||
CBAT | US$1.32 | 18.9% | 73.1% | US$114.2m | US$2.50 | PE13.5x | E56.6% | n/a | Capital Goods | ||
MBI | US$5.93 | -11.8% | -26.0% | US$305.6m | US$9.17 | PE-0.6x | E152.0% | n/a | Insurance | ||
TBPH | US$9.60 | 1.4% | -11.8% | US$479.0m | US$15.40 | PS7.6x | E66.3% | n/a | Pharmaceuticals & Biotech | ||
LNKB | US$6.64 | 5.2% | 32.0% | US$242.8m | US$8.17 | PB0.9x | E87.4% | 4.5% | Banks | ||
LVO | US$1.81 | -3.5% | 14.6% | US$175.3m | US$4.75 | PS1.5x | E94.4% | n/a | Media | ||
CIFR | US$4.07 | 3.0% | 71.0% | US$1.3b | US$5.83 | PE67.6x | E16.3% | n/a | Software | ||
TEAM | US$182.21 | 1.3% | 23.0% | US$47.9b | US$240.61 | PS11.4x | E41.3% | n/a | Software | ||
VCTR | US$52.05 | -0.4% | 60.4% | US$3.4b | US$51.50 | PE15.3x | E30.6% | 2.8% | Diversified Financials | ||
VRCA | US$9.13 | 16.5% | 54.0% | US$386.0m | US$14.17 | PS43.5x | E65.9% | n/a | Pharmaceuticals & Biotech | ||
APP | US$83.18 | -1.8% | 231.7% | US$27.7b | US$93.24 | PE46.1x | E24.7% | n/a | Software |